img

Global COVID-19 Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global COVID-19 Drugs Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal COVID-19 Drugs Market
Global COVID-19 Drugs market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2023 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, COVID-19 Drugs industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2023, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2023. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2023. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global COVID-19 Drugs market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global COVID-19 Drugs market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories
Bayer
Rising Pharmaceutical
Shanghai Pharma
Sichuan Sunny Hope
Guangzhou Baiyunshan Guanghua Pharmaceutical
CSPC Group
KPC Group
Jinghua Pharmaceutical Group
Zhongsheng Pharma
North China Pharmaceutical Group
Segment by Type
Tablet
Injection

Segment by Application


Mild Symptom Patient
Critically Ill Patient
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, COVID-19 Drugs introduction, etc. COVID-19 Drugs Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRA Research’s Conclusions of COVID-19 Drugs
Chapter 13Methodology and Data Sources adopted by MRA Research

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Drugs Market Size Growth Rate by Type, 2018 VS 2023 VS 2033
1.2.2 Tablet
1.2.3 Injection
1.3 Market by Application
1.3.1 Global COVID-19 Drugs Market Size Growth Rate by Application, 2018 VS 2023 VS 2033
1.3.2 Mild Symptom Patient
1.3.3 Critically Ill Patient
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Drugs Market Perspective (2018-2033)
2.2 Global COVID-19 Drugs Growth Trends by Region
2.2.1 COVID-19 Drugs Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 COVID-19 Drugs Historic Market Size by Region (2018-2023)
2.2.3 COVID-19 Drugs Forecasted Market Size by Region (2024-2033)
2.3 COVID-19 Drugs Market Dynamics
2.3.1 COVID-19 Drugs Industry Trends
2.3.2 COVID-19 Drugs Market Drivers
2.3.3 COVID-19 Drugs Market Challenges
2.3.4 COVID-19 Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue COVID-19 Drugs by Players
3.1.1 Global COVID-19 Drugs Revenue by Players (2018-2023)
3.1.2 Global COVID-19 Drugs Revenue Market Share by Players (2018-2023)
3.2 Global COVID-19 Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of COVID-19 Drugs, Ranking by Revenue, 2021 VS 2023 VS 2023
3.4 Global COVID-19 Drugs Market Concentration Ratio
3.4.1 Global COVID-19 Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Drugs Revenue in 2023
3.5 Global Key Players of COVID-19 Drugs Head office and Area Served
3.6 Global Key Players of COVID-19 Drugs, Product and Application
3.7 Global Key Players of COVID-19 Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Drugs Breakdown Data by Type
4.1 Global COVID-19 Drugs Historic Market Size by Type (2018-2023)
4.2 Global COVID-19 Drugs Forecasted Market Size by Type (2024-2033)
5 COVID-19 Drugs Breakdown Data by Application
5.1 Global COVID-19 Drugs Historic Market Size by Application (2018-2023)
5.2 Global COVID-19 Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America COVID-19 Drugs Market Size (2018-2033)
6.2 North America COVID-19 Drugs Market Size by Type
6.2.1 North America COVID-19 Drugs Market Size by Type (2018-2023)
6.2.2 North America COVID-19 Drugs Market Size by Type (2024-2033)
6.2.3 North America COVID-19 Drugs Market Share by Type (2018-2033)
6.3 North America COVID-19 Drugs Market Size by Application
6.3.1 North America COVID-19 Drugs Market Size by Application (2018-2023)
6.3.2 North America COVID-19 Drugs Market Size by Application (2024-2033)
6.3.3 North America COVID-19 Drugs Market Share by Application (2018-2033)
6.4 North America COVID-19 Drugs Market Size by Country
6.4.1 North America COVID-19 Drugs Market Size by Country: 2018 VS 2023 VS 2033
6.4.2 North America COVID-19 Drugs Market Size by Country (2018-2023)
6.4.3 North America COVID-19 Drugs Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe COVID-19 Drugs Market Size (2018-2033)
7.2 Europe COVID-19 Drugs Market Size by Type
7.2.1 Europe COVID-19 Drugs Market Size by Type (2018-2023)
7.2.2 Europe COVID-19 Drugs Market Size by Type (2024-2033)
7.2.3 Europe COVID-19 Drugs Market Share by Type (2018-2033)
7.3 Europe COVID-19 Drugs Market Size by Application
7.3.1 Europe COVID-19 Drugs Market Size by Application (2018-2023)
7.3.2 Europe COVID-19 Drugs Market Size by Application (2024-2033)
7.3.3 Europe COVID-19 Drugs Market Share by Application (2018-2033)
7.4 Europe COVID-19 Drugs Market Size by Country
7.4.1 Europe COVID-19 Drugs Market Size by Country: 2018 VS 2023 VS 2033
7.4.2 Europe COVID-19 Drugs Market Size by Country (2018-2023)
7.4.3 Europe COVID-19 Drugs Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China COVID-19 Drugs Market Size (2018-2033)
8.2 China COVID-19 Drugs Market Size by Type
8.2.1 China COVID-19 Drugs Market Size by Type (2018-2023)
8.2.2 China COVID-19 Drugs Market Size by Type (2024-2033)
8.2.3 China COVID-19 Drugs Market Share by Type (2018-2033)
8.3 China COVID-19 Drugs Market Size by Application
8.3.1 China COVID-19 Drugs Market Size by Application (2018-2023)
8.3.2 China COVID-19 Drugs Market Size by Application (2024-2033)
8.3.3 China COVID-19 Drugs Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia COVID-19 Drugs Market Size (2018-2033)
9.2 Asia COVID-19 Drugs Market Size by Type
9.2.1 Asia COVID-19 Drugs Market Size by Type (2018-2023)
9.2.2 Asia COVID-19 Drugs Market Size by Type (2024-2033)
9.2.3 Asia COVID-19 Drugs Market Share by Type (2018-2033)
9.3 Asia COVID-19 Drugs Market Size by Application
9.3.1 Asia COVID-19 Drugs Market Size by Application (2018-2023)
9.3.2 Asia COVID-19 Drugs Market Size by Application (2024-2033)
9.3.3 Asia COVID-19 Drugs Market Share by Application (2018-2033)
9.4 Asia COVID-19 Drugs Market Size by Region
9.4.1 Asia COVID-19 Drugs Market Size by Region: 2018 VS 2023 VS 2033
9.4.2 Asia COVID-19 Drugs Market Size by Region (2018-2023)
9.4.3 Asia COVID-19 Drugs Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America COVID-19 Drugs Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America COVID-19 Drugs Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America COVID-19 Drugs Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country: 2018 VS 2023 VS 2033
10.4.2 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi COVID-19 Drugs Introduction
11.1.4 Sanofi Revenue in COVID-19 Drugs Business (2018-2023)
11.1.5 Sanofi Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis COVID-19 Drugs Introduction
11.2.4 Novartis Revenue in COVID-19 Drugs Business (2018-2023)
11.2.5 Novartis Recent Developments
11.3 Shanghai Zhongxisanwei
11.3.1 Shanghai Zhongxisanwei Company Details
11.3.2 Shanghai Zhongxisanwei Business Overview
11.3.3 Shanghai Zhongxisanwei COVID-19 Drugs Introduction
11.3.4 Shanghai Zhongxisanwei Revenue in COVID-19 Drugs Business (2018-2023)
11.3.5 Shanghai Zhongxisanwei Recent Developments
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva COVID-19 Drugs Introduction
11.4.4 Teva Revenue in COVID-19 Drugs Business (2018-2023)
11.4.5 Teva Recent Developments
11.5 Zydus Cadila
11.5.1 Zydus Cadila Company Details
11.5.2 Zydus Cadila Business Overview
11.5.3 Zydus Cadila COVID-19 Drugs Introduction
11.5.4 Zydus Cadila Revenue in COVID-19 Drugs Business (2018-2023)
11.5.5 Zydus Cadila Recent Developments
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan COVID-19 Drugs Introduction
11.6.4 Mylan Revenue in COVID-19 Drugs Business (2018-2023)
11.6.5 Mylan Recent Developments
11.7 Apotex
11.7.1 Apotex Company Details
11.7.2 Apotex Business Overview
11.7.3 Apotex COVID-19 Drugs Introduction
11.7.4 Apotex Revenue in COVID-19 Drugs Business (2018-2023)
11.7.5 Apotex Recent Developments
11.8 Advanz Pharma
11.8.1 Advanz Pharma Company Details
11.8.2 Advanz Pharma Business Overview
11.8.3 Advanz Pharma COVID-19 Drugs Introduction
11.8.4 Advanz Pharma Revenue in COVID-19 Drugs Business (2018-2023)
11.8.5 Advanz Pharma Recent Developments
11.9 Sun Pharma
11.9.1 Sun Pharma Company Details
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma COVID-19 Drugs Introduction
11.9.4 Sun Pharma Revenue in COVID-19 Drugs Business (2018-2023)
11.9.5 Sun Pharma Recent Developments
11.10 Kyung Poong
11.10.1 Kyung Poong Company Details
11.10.2 Kyung Poong Business Overview
11.10.3 Kyung Poong COVID-19 Drugs Introduction
11.10.4 Kyung Poong Revenue in COVID-19 Drugs Business (2018-2023)
11.10.5 Kyung Poong Recent Developments
11.11 Ipca Laboratories
11.11.1 Ipca Laboratories Company Details
11.11.2 Ipca Laboratories Business Overview
11.11.3 Ipca Laboratories COVID-19 Drugs Introduction
11.11.4 Ipca Laboratories Revenue in COVID-19 Drugs Business (2018-2023)
11.11.5 Ipca Laboratories Recent Developments
11.12 Hanlim Pharmaceutical
11.12.1 Hanlim Pharmaceutical Company Details
11.12.2 Hanlim Pharmaceutical Business Overview
11.12.3 Hanlim Pharmaceutical COVID-19 Drugs Introduction
11.12.4 Hanlim Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023)
11.12.5 Hanlim Pharmaceutical Recent Developments
11.13 Bristol Laboratories
11.13.1 Bristol Laboratories Company Details
11.13.2 Bristol Laboratories Business Overview
11.13.3 Bristol Laboratories COVID-19 Drugs Introduction
11.13.4 Bristol Laboratories Revenue in COVID-19 Drugs Business (2018-2023)
11.13.5 Bristol Laboratories Recent Developments
11.14 Bayer
11.14.1 Bayer Company Details
11.14.2 Bayer Business Overview
11.14.3 Bayer COVID-19 Drugs Introduction
11.14.4 Bayer Revenue in COVID-19 Drugs Business (2018-2023)
11.14.5 Bayer Recent Developments
11.15 Rising Pharmaceutical
11.15.1 Rising Pharmaceutical Company Details
11.15.2 Rising Pharmaceutical Business Overview
11.15.3 Rising Pharmaceutical COVID-19 Drugs Introduction
11.15.4 Rising Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023)
11.15.5 Rising Pharmaceutical Recent Developments
11.16 Shanghai Pharma
11.16.1 Shanghai Pharma Company Details
11.16.2 Shanghai Pharma Business Overview
11.16.3 Shanghai Pharma COVID-19 Drugs Introduction
11.16.4 Shanghai Pharma Revenue in COVID-19 Drugs Business (2018-2023)
11.16.5 Shanghai Pharma Recent Developments
11.17 Sichuan Sunny Hope
11.17.1 Sichuan Sunny Hope Company Details
11.17.2 Sichuan Sunny Hope Business Overview
11.17.3 Sichuan Sunny Hope COVID-19 Drugs Introduction
11.17.4 Sichuan Sunny Hope Revenue in COVID-19 Drugs Business (2018-2023)
11.17.5 Sichuan Sunny Hope Recent Developments
11.18 Guangzhou Baiyunshan Guanghua Pharmaceutical
11.18.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
11.18.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
11.18.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Introduction
11.18.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023)
11.18.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
11.19 CSPC Group
11.19.1 CSPC Group Company Details
11.19.2 CSPC Group Business Overview
11.19.3 CSPC Group COVID-19 Drugs Introduction
11.19.4 CSPC Group Revenue in COVID-19 Drugs Business (2018-2023)
11.19.5 CSPC Group Recent Developments
11.20 KPC Group
11.20.1 KPC Group Company Details
11.20.2 KPC Group Business Overview
11.20.3 KPC Group COVID-19 Drugs Introduction
11.20.4 KPC Group Revenue in COVID-19 Drugs Business (2018-2023)
11.20.5 KPC Group Recent Developments
11.21 Jinghua Pharmaceutical Group
11.21.1 Jinghua Pharmaceutical Group Company Details
11.21.2 Jinghua Pharmaceutical Group Business Overview
11.21.3 Jinghua Pharmaceutical Group COVID-19 Drugs Introduction
11.21.4 Jinghua Pharmaceutical Group Revenue in COVID-19 Drugs Business (2018-2023)
11.21.5 Jinghua Pharmaceutical Group Recent Developments
11.22 Zhongsheng Pharma
11.22.1 Zhongsheng Pharma Company Details
11.22.2 Zhongsheng Pharma Business Overview
11.22.3 Zhongsheng Pharma COVID-19 Drugs Introduction
11.22.4 Zhongsheng Pharma Revenue in COVID-19 Drugs Business (2018-2023)
11.22.5 Zhongsheng Pharma Recent Developments
11.23 North China Pharmaceutical Group
11.23.1 North China Pharmaceutical Group Company Details
11.23.2 North China Pharmaceutical Group Business Overview
11.23.3 North China Pharmaceutical Group COVID-19 Drugs Introduction
11.23.4 North China Pharmaceutical Group Revenue in COVID-19 Drugs Business (2018-2023)
11.23.5 North China Pharmaceutical Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global COVID-19 Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Tablet
Table 3. Key Players of Injection
Table 4. Global COVID-19 Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 5. Global COVID-19 Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 6. Global COVID-19 Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global COVID-19 Drugs Market Share by Region (2018-2023)
Table 8. Global COVID-19 Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global COVID-19 Drugs Market Share by Region (2024-2033)
Table 10. COVID-19 Drugs Market Trends
Table 11. COVID-19 Drugs Market Drivers
Table 12. COVID-19 Drugs Market Challenges
Table 13. COVID-19 Drugs Market Restraints
Table 14. Global COVID-19 Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global COVID-19 Drugs Revenue Share by Players (2018-2023)
Table 16. Global Top COVID-19 Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Drugs as of 2023)
Table 17. Global COVID-19 Drugs Industry Ranking 2021 VS 2023 VS 2023
Table 18. Global 5 Largest Players Market Share by COVID-19 Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of COVID-19 Drugs, Headquarters and Area Served
Table 20. Global Key Players of COVID-19 Drugs, Product and Application
Table 21. Global Key Players of COVID-19 Drugs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global COVID-19 Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global COVID-19 Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global COVID-19 Drugs Revenue Market Share by Type (2024-2033)
Table 27. Global COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global COVID-19 Drugs Revenue Share by Application (2018-2023)
Table 29. Global COVID-19 Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global COVID-19 Drugs Revenue Share by Application (2024-2033)
Table 31. North America COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America COVID-19 Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America COVID-19 Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America COVID-19 Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 36. North America COVID-19 Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America COVID-19 Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe COVID-19 Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe COVID-19 Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe COVID-19 Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 43. Europe COVID-19 Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe COVID-19 Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 45. China COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 46. China COVID-19 Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 47. China COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 48. China COVID-19 Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia COVID-19 Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia COVID-19 Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia COVID-19 Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 54. Asia COVID-19 Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia COVID-19 Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America COVID-19 Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 61. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America COVID-19 Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi COVID-19 Drugs Product
Table 66. Sanofi Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 67. Sanofi Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis COVID-19 Drugs Product
Table 71. Novartis Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Shanghai Zhongxisanwei Company Details
Table 74. Shanghai Zhongxisanwei Business Overview
Table 75. Shanghai Zhongxisanwei COVID-19 Drugs Product
Table 76. Shanghai Zhongxisanwei Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 77. Shanghai Zhongxisanwei Recent Developments
Table 78. Teva Company Details
Table 79. Teva Business Overview
Table 80. Teva COVID-19 Drugs Product
Table 81. Teva Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 82. Teva Recent Developments
Table 83. Zydus Cadila Company Details
Table 84. Zydus Cadila Business Overview
Table 85. Zydus Cadila COVID-19 Drugs Product
Table 86. Zydus Cadila Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 87. Zydus Cadila Recent Developments
Table 88. Mylan Company Details
Table 89. Mylan Business Overview
Table 90. Mylan COVID-19 Drugs Product
Table 91. Mylan Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 92. Mylan Recent Developments
Table 93. Apotex Company Details
Table 94. Apotex Business Overview
Table 95. Apotex COVID-19 Drugs Product
Table 96. Apotex Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 97. Apotex Recent Developments
Table 98. Advanz Pharma Company Details
Table 99. Advanz Pharma Business Overview
Table 100. Advanz Pharma COVID-19 Drugs Product
Table 101. Advanz Pharma Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 102. Advanz Pharma Recent Developments
Table 103. Sun Pharma Company Details
Table 104. Sun Pharma Business Overview
Table 105. Sun Pharma COVID-19 Drugs Product
Table 106. Sun Pharma Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 107. Sun Pharma Recent Developments
Table 108. Kyung Poong Company Details
Table 109. Kyung Poong Business Overview
Table 110. Kyung Poong COVID-19 Drugs Product
Table 111. Kyung Poong Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 112. Kyung Poong Recent Developments
Table 113. Ipca Laboratories Company Details
Table 114. Ipca Laboratories Business Overview
Table 115. Ipca Laboratories COVID-19 Drugs Product
Table 116. Ipca Laboratories Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 117. Ipca Laboratories Recent Developments
Table 118. Hanlim Pharmaceutical Company Details
Table 119. Hanlim Pharmaceutical Business Overview
Table 120. Hanlim Pharmaceutical COVID-19 Drugs Product
Table 121. Hanlim Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 122. Hanlim Pharmaceutical Recent Developments
Table 123. Bristol Laboratories Company Details
Table 124. Bristol Laboratories Business Overview
Table 125. Bristol Laboratories COVID-19 Drugs Product
Table 126. Bristol Laboratories Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 127. Bristol Laboratories Recent Developments
Table 128. Bayer Company Details
Table 129. Bayer Business Overview
Table 130. Bayer COVID-19 Drugs Product
Table 131. Bayer Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 132. Bayer Recent Developments
Table 133. Rising Pharmaceutical Company Details
Table 134. Rising Pharmaceutical Business Overview
Table 135. Rising Pharmaceutical COVID-19 Drugs Product
Table 136. Rising Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 137. Rising Pharmaceutical Recent Developments
Table 138. Shanghai Pharma Company Details
Table 139. Shanghai Pharma Business Overview
Table 140. Shanghai Pharma COVID-19 Drugs Product
Table 141. Shanghai Pharma Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 142. Shanghai Pharma Recent Developments
Table 143. Sichuan Sunny Hope Company Details
Table 144. Sichuan Sunny Hope Business Overview
Table 145. Sichuan Sunny Hope COVID-19 Drugs Product
Table 146. Sichuan Sunny Hope Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 147. Sichuan Sunny Hope Recent Developments
Table 148. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
Table 149. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
Table 150. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product
Table 151. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 152. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
Table 153. CSPC Group Company Details
Table 154. CSPC Group Business Overview
Table 155. CSPC Group COVID-19 Drugs Product
Table 156. CSPC Group Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 157. CSPC Group Recent Developments
Table 158. KPC Group Company Details
Table 159. KPC Group Business Overview
Table 160. KPC Group COVID-19 Drugs Product
Table 161. KPC Group Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 162. KPC Group Recent Developments
Table 163. Jinghua Pharmaceutical Group Company Details
Table 164. Jinghua Pharmaceutical Group Business Overview
Table 165. Jinghua Pharmaceutical Group COVID-19 Drugs Product
Table 166. Jinghua Pharmaceutical Group Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 167. Jinghua Pharmaceutical Group Recent Developments
Table 168. Zhongsheng Pharma Company Details
Table 169. Zhongsheng Pharma Business Overview
Table 170. Zhongsheng Pharma COVID-19 Drugs Product
Table 171. Zhongsheng Pharma Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 172. Zhongsheng Pharma Recent Developments
Table 173. North China Pharmaceutical Group Company Details
Table 174. North China Pharmaceutical Group Business Overview
Table 175. North China Pharmaceutical Group COVID-19 Drugs Product
Table 176. North China Pharmaceutical Group Revenue in COVID-19 Drugs Business (2018-2023) & (US$ Million)
Table 177. North China Pharmaceutical Group Recent Developments
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Drugs Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million)
Figure 2. Global COVID-19 Drugs Market Share by Type: 2023 VS 2033
Figure 3. Tablet Features
Figure 4. Injection Features
Figure 5. Global COVID-19 Drugs Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million)
Figure 6. Global COVID-19 Drugs Market Share by Application: 2023 VS 2033
Figure 7. Mild Symptom Patient Case Studies
Figure 8. Critically Ill Patient Case Studies
Figure 9. COVID-19 Drugs Report Years Considered
Figure 10. Global COVID-19 Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global COVID-19 Drugs Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 12. Global COVID-19 Drugs Market Share by Region: 2023 VS 2033
Figure 13. Global COVID-19 Drugs Market Share by Players in 2023
Figure 14. Global Top COVID-19 Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Drugs as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by COVID-19 Drugs Revenue in 2023
Figure 16. North America COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America COVID-19 Drugs Market Share by Type (2018-2033)
Figure 18. North America COVID-19 Drugs Market Share by Application (2018-2033)
Figure 19. North America COVID-19 Drugs Market Share by Country (2018-2033)
Figure 20. United States COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe COVID-19 Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 23. Europe COVID-19 Drugs Market Share by Type (2018-2033)
Figure 24. Europe COVID-19 Drugs Market Share by Application (2018-2033)
Figure 25. Europe COVID-19 Drugs Market Share by Country (2018-2033)
Figure 26. Germany COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. China COVID-19 Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 33. China COVID-19 Drugs Market Share by Type (2018-2033)
Figure 34. China COVID-19 Drugs Market Share by Application (2018-2033)
Figure 35. Asia COVID-19 Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 36. Asia COVID-19 Drugs Market Share by Type (2018-2033)
Figure 37. Asia COVID-19 Drugs Market Share by Application (2018-2033)
Figure 38. Asia COVID-19 Drugs Market Share by Region (2018-2033)
Figure 39. Japan COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. South Korea COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. China Taiwan COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Southeast Asia COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. India COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Australia COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America COVID-19 Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America COVID-19 Drugs Market Share by Type (2018-2033)
Figure 47. Middle East, Africa, and Latin America COVID-19 Drugs Market Share by Application (2018-2033)
Figure 48. Middle East, Africa, and Latin America COVID-19 Drugs Market Share by Country (2018-2033)
Figure 49. Brazil COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Mexico COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Turkey COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Israel COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. GCC Countries COVID-19 Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Sanofi Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 56. Novartis Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 57. Shanghai Zhongxisanwei Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 58. Teva Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 59. Zydus Cadila Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 60. Mylan Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 61. Apotex Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 62. Advanz Pharma Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 63. Sun Pharma Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 64. Kyung Poong Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 65. Ipca Laboratories Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 66. Hanlim Pharmaceutical Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 67. Bristol Laboratories Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 68. Bayer Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 69. Rising Pharmaceutical Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 70. Shanghai Pharma Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 71. Sichuan Sunny Hope Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 72. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 73. CSPC Group Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 74. KPC Group Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 75. Jinghua Pharmaceutical Group Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 76. Zhongsheng Pharma Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 77. North China Pharmaceutical Group Revenue Growth Rate in COVID-19 Drugs Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries